BPG is committed to discovery and dissemination of knowledge
Welcome to the World Journal of Hepatology

The World Journal of Hepatology (WJH) is a leading academic journal devoted to reporting the latest, cutting-edge research progress and findings of basic research and clinical practice in the field of hepatology.  It was launched on October 31, 2009 and is published monthly (36 issues annually) by BPG, the world's leading professional clinical medical journal publishing company.

We encourage hepatologists worldwide to submit manuscripts to the WJH describing their original basic or clinical research findings that are of high academic value and which report new diagnostic techniques or summarize their treatment experiences.

The usual times related to all publication processes of the WJH are as follows: (1) From manuscript receipt to peer-review: 2-4 weeks; (2) From initial manuscript acceptance, with revisions, to return of the revised manuscript from the authors: 4-5 weeks; (3) From return of the revised manuscript from the authors to final acceptance: 1-2 weeks; (4) From final acceptance to an article in press: 2 days; and (5) From article in press designation to formal release of the electronic version and all online documentation: 2-9 weeks.The WJH’s acceptance rate: 51%. Submit here >>

2017 Published Issues
5 4 3 2 1
Editors-in-Chief

Clara Balsano, PhD, Professor; Wan-Long Chuang, MD, PhD, Doctor, Professor

Indexing/Abstracting

PubMed, PubMed Central, and Scopus.

Journal Metrics

SJR (SCImago Journal Rank) (2015): 0.858; IPP (Impact per Publication) (2015): 2.730; SNIP (Source Normalized Impact per Paper) (2015): 1.206; and CiteScore (2015) 3.19.

ISSN

1948-5182 (online)

Review
Adverse effects of oral antiviral therapy in chronic hepatitis B  
Bircan Kayaaslan, Rahmet Guner
World J Hepatol 9(5):227-241. Published online Feb 18, 2017. doi: 10.4254/wjh.v9.i5.227
Role of surgical resection for non-colorectal non-neuroendocrine liver metastases  
Nobuyuki Takemura, Akio Saiura
World J Hepatol 9(5):242-251. Published online Feb 18, 2017. doi: 10.4254/wjh.v9.i5.242
Retrospective Study
Efficacy and safety of telaprevir- and simeprevir-based triple therapies for older patients with chronic hepatitis C  
Satoshi Yamagiwa, Toru Ishikawa, Nobuo Waguri, Soichi Sugitani, Hiroto Wakabayashi, Shogo Ohkoshi, Takashi Tsukishiro, Toru Takahashi, Toshiaki Watanabe, Shuji Terai
World J Hepatol 9(5):252-262. Published online Feb 18, 2017. doi: 10.4254/wjh.v9.i5.252
Observational Study
Malnutrition negatively impacts the quality of life of patients with cirrhosis: An observational study  
Gabriela Rojas-Loureiro, Alfredo Servín-Caamaño, Elizabeth Pérez-Reyes, Luis Servín-Abad, Fátima Higuera-de la Tijera
World J Hepatol 9(5):263-269. Published online Feb 18, 2017. doi: 10.4254/wjh.v9.i5.263
Addition of simvastatin to carvedilol non responders: A new pharmacological therapy for treatment of portal hypertension  
Zeeshan Ahmad Wani, Sonmoon Mohapatra, Afaq Ahmad Khan, Ashutosh Mohapatra, Ghulam Nabi Yatoo
World J Hepatol 9(5):270-277. Published online Feb 18, 2017. doi: 10.4254/wjh.v9.i5.270
Systematic Reviews
Influence of vitamin D on liver fibrosis in chronic hepatitis C: A systematic review and meta-analysis of the pooled clinical trials data  
Alia S Dadabhai, Behnam Saberi, Katie Lobner, Russell T Shinohara, Gerard E Mullin
World J Hepatol 9(5):278-287. Published online Feb 18, 2017. doi: 10.4254/wjh.v9.i5.278
Meta-Analysis
Is it time to rethink combined liver-kidney transplant in hepatitis C patients with advanced fibrosis?  
Niraj James Shah, Mark W Russo
World J Hepatol 9(5):288-292. Published online Feb 18, 2017. doi: 10.4254/wjh.v9.i5.288